AZAR/HAHN COVID PRESS CONFERENCE ON PLASMA THERAPY PROGRESS

<p>Health and Human Services Director Alex Azar and Dr Stephen Hahn, FDA Commissioner, both presented an update on what is described as promising treatment of COVID 19 patients with a 35% reduction in fatality rates when former patients who have recovered from COVID 19 donate blood plasma which is used in therapy for serious COVID 19 patients.</p> <p>Here is the unedited audio of Azar and Hahn from Sunday at a White House briefing.</p> --- Support this podcast: <a href="https://anchor.fm/james-watkins9/support" rel="payment">https://anchor.fm/james-watkins9/support</a>